Bank Of America Corp Biocryst Pharmaceuticals Inc Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 1,300,338 shares of BCRX stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,300,338

Previous 1,366,167 4.82%

Holding current value

$10.1 Million

Previous $6.94 Million 15.79%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.13 - $6.79 $271,873 - $446,978	-65,829 Reduced 4.82%	1,300,338 $8.04 Million
Q1 2024 May 15, 2024	SELL	$4.89 - $7.65 $264,681 - $414,071	-54,127 Reduced 3.81%	1,366,167 $6.94 Million
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $309,437 - $420,660	62,136 Added 4.58%	1,420,294 $8.51 Million
Q2 2023 Aug 14, 2023	SELL	$6.96 - $8.81 $15.7 Million - $19.9 Million	-2,256,175 Reduced 62.42%	1,358,158 $9.56 Million
Q1 2023 May 12, 2023	BUY	$7.94 - $11.84 $20.9 Million - $31.1 Million	2,627,536 Added 266.27%	3,614,333 $30.1 Million
Q4 2022 Feb 10, 2023	BUY	$10.5 - $14.2 $1.39 Million - $1.87 Million	131,916 Added 15.43%	986,797 $11.3 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $997,492 - $1.37 Million	92,446 Added 12.13%	854,881 $10.8 Million
Q2 2022 Aug 12, 2022	BUY	$7.89 - $17.88 $205,092 - $464,772	25,994 Added 3.53%	762,435 $8.07 Million
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $4.39 Million - $7.5 Million	379,757 Added 106.47%	736,441 $12 Million
Q4 2021 Feb 08, 2022	SELL	$11.18 - $15.46 $2.52 Million - $3.48 Million	-224,960 Reduced 38.68%	356,684 $4.94 Million
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $5.52 Million - $6.86 Million	-388,484 Reduced 40.04%	581,644 $8.36 Million
Q2 2021 Sep 13, 2021	BUY	$9.5 - $17.24 $9.22 Million - $16.7 Million	970,128 New	970,128 $15.3 Million

Others Institutions Holding BCRX

# of Institutions

258

Shares Held

173M

Call Options Held

397K

Put Options Held

444K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.44B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Biocryst Pharmaceuticals Inc Transaction History